CUET UG Biology Booster Test 2-Molecular Diagnostics & Transgenic Animals

Understanding pathophysiology is the study of how disease processes change normal body functions. By grasping these mechanisms, scientists can design diagnostic tools (like PCR/ELIS A) to detect minute amounts of pathogen DNA or antigens. Option B is correct because early detection targets the disease at a sub-clinical stage, ensuring treatment is administered when the pathogen load is low, which significantly improves the prognosis compared to waiting for symptom-based conventional diagnosis.

Conventional diagnostic methods (serum/urine analysis) usually require a patient to present clinical symptoms, which implies the pathogen has already proliferated significantly. PCR (Polymerase Chain Reaction) amplifies pathogen DNA, and ELISA detects specific protein-antigen interactions, allowing for detection long before the pathogen becomes visible or symptoms appear. Option B is the only accurate description of their molecular advantage.

PCR is based on the ability to amplify even a few copies of a pathogen's nucleic acid (DNA/RN A) into billions of copies, making it detectable. ELISA (Enzyme-Linked Immuno-Sorbent Assay) is based on the specificity of antigen-antibody reactions; the enzyme-linked antibody creates a color change indicating the presence of the antigen. Thus, 1-i and 2-ii is the only correct matching.

PCR is used to detect mutations in genes in suspected cancer patients (1-ii), as PCR can amplify the specific mutant sequences. For suspected AIDS patients (2-i), PCR is used to detect the presence of HIV viral nucleic acid long before antibodies are produced in high enough quantities to be detected by other methods.

The logical flow begins with the arrival of a pathogen, which introduces antigens (1). The host's immune system recognizes these as foreign and creates specific antibodies (2). The diagnostic tool (ELIS A) then exploits this biological relationship by detecting the binding between the captured antigen and the added antibody (3).

The diagnostic workflow begins when a patient shows early signs suggestive of infection (2). This leads to the performance of an ELISA test (1). ELISA then detects specific antigens/glycoproteins associated with the pathogen (3).

Statement I is incorrect because a probe must be single-stranded DNA or RNA to hybridize (base-pair) with its complementary target. Statement II is correct as radioactive markers are used for detection. Statement III is correct because hybridization is specifically used to find a gene of interest in a clone of cells by detecting the complementary sequence.

Statement I is correct; autoradiography is the process of using photographic film to detect radioactive decay. Statement III is correct; if the probe does not bind to the mutated gene (because the mutation altered the sequence), no radioactivity is present in that location, so the film remains blank. Statement II is incorrect because the mutated gene, which lacks complementarity to the probe, would not appear; the normal (complementary) gene would appear as a signal.

Option B is the correct answer to the "NOT" question because it is factually false. Mice are the most common transgenic animals, not the least, accounting for the vast majority of research models due to their short generation times and well-understood genome.

Transgenic mice for polio testing are engineered to express the human receptor for the polio virus, making them susceptible to infection. This allows researchers to test vaccine safety. Option C is the correct answer to the "NOT" question because claiming they are engineered to be "completely immune" contradicts the entire purpose of creating them as a disease model.

Transgenic animals are primarily created for medical research and understanding biological processes. Options A, B, and D are standard scientific applications. Option C is entirely incorrect and does not constitute a legitimate scientific use or application of transgenic technology.

Studying growth factors involves analyzing the changes in biological processes when these factors are altered (overexpressed or silence D). Option D is incorrect because it describes a lethal and non-informative approach; researchers want to observe the effects of the factor's presence or modification, not prevent the animal from growing entirely.

Transgenic animals allow scientists to introduce specific disease-causing genes (or human disease models) into an animal. This creates a "human-like" biological environment to test the efficacy and safety of potential treatments before moving to human trials, which is critical for ethical and safety reasons.

Creating a transgenic model for a disease like Alzheimer's allows scientists to simulate the disease pathology in an animal. This facilitates the investigation of how the disease progresses and provides a platform to test new therapeutic treatments, which is the primary research utility.

To make a transgenic animal produce a specific protein, scientists introduce the gene (DN A) that encodes that protein into the animal's genome. This directs the animal's cells to produce the product. Option A is the definition of the molecular technique used.

Alpha-1-antitrypsin is a protein used to treat emphysema. The transgenic production of this protein is a classic example highlighted in biotechnology for producing biological products for human disease.

Rosie was produced in 1997 and was capable of producing milk enriched with human alpha-lactalbumin (2.4 grams per litre), making it nutritionally more balanced for human babies than natural cow milk.

The transgenic cow Rosie, which produced human alpha-lactalbumin enriched milk, was created in 1997. This is a direct factual question from the NCERT curriculum regarding biotechnology milestones.

For chemical safety/toxicity testing, we want animals that respond clearly and quickly to toxic substances. By being "more sensitive," these animals show observable effects at lower concentrations of the chemical, making the test faster and more accurate for human risk assessment.

Because transgenic animals are more sensitive to toxic substances, they react more quickly to harmful chemicals. This allows researchers to get clear, conclusive data regarding toxicity in a shorter period compared to using non-transgenic animals, which might require long-term observation to show the same toxic effects.